Table: begin end state 1 6 cytoplasmic 7 27 transmembrane 28 32 non-cytoplasmic 33 53 transmembrane 54 64 cytoplasmic 65 83 transmembrane 84 88 non-cytoplasmic 89 108 transmembrane 109 114 cytoplasmic 115 134 transmembrane 135 162 non-cytoplasmic 163 181 transmembrane 182 211 cytoplasmic 212 232 transmembrane 233 250 non-cytoplasmic 251 274 transmembrane 275 285 cytoplasmic 286 305 transmembrane 306 602 non-cytoplasmic
Input: >WP_093394842.1 NCBI__GCF_900114975.1:WP_093394842.1 MRVEKKTAIYFPALICLSLSGLFLPSFIKNDYLFVILNVVAFNGIAVTGLNLLYDATGQV SLGHAVFYGLGAYTTAVLSVTFGLPLWTAWMGSVAMVLVSSFILAFPTLRLHGHYMVMAT LGCNIILTVILNQWESLTGGPSGFPGIPELSAGFVELSTDRGFFRLAWIALLGFAFATVA LQKSGVGKIFRAIRQNEIATECCGTNTTGYKIFAFVLSALYAGIAGILYAHYMSFISPKT FGVFRSLEWVTMAVVGGMGNVLGGILGAFVLTLLPELLHALEELQVLFYGIVLMSVLILC PQGMVPAIRSLVDRFSALTETEACGDKSLKKKTLRGATPVRAGRNCGKLRIEGLSVNFGG LQALSSVSVTFDPGRIHAVIGPNGAGKTTLFNAVCGIVKPRSGKIFLGDLEITGFSPHKI ALSGIGRTFQVPQLYSEFSVRDHVFVGMCVGRLPLNGMIGDDVDEVLRFFDLLELSELKV GEVSLFDKKRIELARALAANPAYILVDEPGGGLNEEEKEAVARYLFALTKVGVTPIVVDH HMDLVMNVAERVVVLHQGQIIADGTPDEIVENPRVADAYLGSRQKVLSGGRVERGCEGCG NA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server